Comparative effects of sandalwood seed oil on fatty acid profiles and inflammatory factors in rats.
Guipu Li, Anish Singh, Yandi Liu, Bruce Sunderland, Duo Li
Index: Lipids 48(2) , 105-13, (2013)
Full Text: HTML
Abstract
The aim of the present study was to investigate the effect of sandalwood seed oil on fatty acid (FA) profiles and inflammatory factors in rats. Fifty male Sprague-Dawley rats were randomly divided into five different dietary groups: 10 % soybean oil (SO), 10 % olive oil (OO), 10 % safflower oil (SFO), 10 % linseed oil (LSO) and 8 % sandalwood seed oil blended with 2 % SO (SWSO) for 8 weeks. The SWSO group had a higher total n-3 polyunsaturated fatty acids (PUFA) levels but lower n-6:n-3 PUFA ratios in both adipose tissue and liver than those in the SO, OO and SFO groups (p < 0.05). Although the SWSO group had a much lower 18:3n-3 level (4.51 %) in their dietary lipids than the LSO group (58.88 %), the levels of docosahexaenoic acid (DHA: 22:6n-3) in liver lipids and phospholipids of the SWSO group (7.52 and 11.77 %) were comparable to those of the LSO group (7.07 and 13.16 %). Ximenynic acid, a predominant acetylenic FA in sandalwood seed oil, was found to be highly incorporated into adipose tissue (13.73 %), but relatively lower in liver (0.51 %) in the SWSO group. The levels of prostaglandin F(2α), prostaglandin E₂, thromboxane B₂, leukotriene B₄, tumor necrosis factor-α and interleukin-1β in both liver and plasma were positively correlated with the n-6:n-3 ratios, suggesting that increased n-6 PUFA appear to increase the formation of pro-inflammatory cytokines, whereas n-3 PUFA exhibit anti-inflammatory activity. The present results suggest that sandalwood seed oil could increase tissue levels of n-3 PUFA, DHA and reduce the n-6:n-3 ratio, and may increase the anti-inflammatory activity in rats.
Related Compounds
Related Articles:
2012-12-01
[Journal. of. Drugs in. Dermatology. 11(12) , 1400, (2012)]
2013-02-01
[Journal. of. Drugs in. Dermatology. 11(12) , 1403-8, (2012)]
2013-02-01
[Nat. Prod. Commun. 8(2) , 253-6, (2013)]
2012-10-07
[Analyst 137(19) , 4564-70, (2012)]
1999-10-01
[Eur. J. Cancer Prev. 8(5) , 449-55, (1999)]